Hepatitis E Diagnostic Tests Market, By Product Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Hepatitis E Diagnostic Tests Market size was valued at USD 53.52 Million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

Hepatitis E diagnostic tests are medical assays designed to detect the presence of the Hepatitis E virus (HEV), which causes liver inflammation. These tests typically utilize serological methods to identify antibodies (anti-HEV IgM and IgG) or molecular techniques such as PCR polymerase chain reaction (PCR) to detect viral RNA. Early and accurate diagnosis is crucial for managing hepatitis E, especially in pregnant women and individuals with compromised liver function, as the infection can result in severe complications. Hepatitis E diagnostics play a vital role in public health monitoring and controlling outbreaks, particularly in regions where the virus is endemic.

Hepatitis E Diagnostic Tests Market- Market Dynamics

Increasing need of early diagnosis and timely treatment to propel market demand

The global market for hepatitis E diagnostics has experienced significant technological advancements in recent years, enhancing the accuracy, efficiency, and accessibility of diagnostic solutions. For instance, in June 2021, DiaSorin launched fully automated high-throughput CLIA solution for the hepatitis E diagnosis, available in countries that accept the CE mark. This new offering represents a important improvement in hepatitis E diagnostics, allowing healthcare providers to conduct high-throughput testing efficiently. This capability is particularly important in regions with high hepatitis E prevalence, where rapid identification of infected individuals is essential for effective disease management and prevention. The introduction of such advanced diagnostic platforms meets the growing demand for accurate and efficient testing solutions. Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also crucial in driving market growth. Increased awareness of the risks and consequences of hepatitis E, including higher mortality rates in pregnant women, is fueling demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List highlights the global recognition of the importance of early detection and management of the disease. Governments and healthcare systems are increasingly acknowledging the need for improved surveillance and outbreak management, leading to greater procurement of HEV diagnostic kits. Additionally, patients and clinicians are seeking better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For example, the Government of India's comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. This program involves significant government funding and a decentralized implementation strategy to enhance the healthcare system's capacity to manage viral hepatitis effectively. Increasing healthcare expenditure, particularly in emerging markets, is also supporting market growth. The emphasis on early detection and effective disease management is driving demand for diagnostic tests. As awareness about hepatitis E grows, there is a heightened focus on implementing preventive measures, including personal hygiene, safe water sources, proper sanitation, and food safety, to mitigate the virus's spread.

Hepatitis E Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on Product Type segmentation, ELISA HEV IgM test was predicted to show maximum market share in the year 2023

Based on End-use segmentation, the hospital was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hepatitis E Diagnostic Tests Market- Segmentation Analysis:

The Global Hepatitis E Diagnostic Tests Market is segmented on the basis of Product Type, End-use, and Region.

The market is divided into four categories based on product type: ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test and Polymerase Chain Reaction (PCR). Based on type, the ELISA HEV IgM test segment led the hepatitis E diagnostic tests market with the largest revenue share in 2023. This dominance is primarily due to the critical role of detecting IgM-class antibodies to the hepatitis E virus (HEV) for identifying acute or recent infections (less than six months). The presence of IgM antibodies is essential for diagnosing acute hepatitis E, typically confirmed by follow-up RNA testing. The high sensitivity and specificity of ELISA-based IgM tests make them the preferred option for initial HEV screening. For example, Dia.Pro offers the HEV-IgM ELISA test kit, specifically designed to detect IgM antibodies against HEV in human serum or plasma. The increasing incidence of hepatitis E infections, especially in developing regions with inadequate sanitation and hygiene practices, has significantly boosted the demand for effective diagnostic tools like the ELISA HEV IgM test.

The market is divided into four categories based on End use: Hospital, Blood Banks, Diagnostics Laboratories, and Other End User. In terms of end use, the hospital segment was leading the market with the largest revenue share in 2023. This trend is primarily driven by the high prevalence of hepatitis E cases being diagnosed and treated in hospitals globally. Hospitals are equipped with advanced diagnostic facilities, a diverse range of healthcare professionals, and the necessary infrastructure to efficiently diagnose and manage hepatitis E cases. Moreover, hospitals often act as referral centers for more complex cases, further enhancing their significant revenue share in the global market.

Hepatitis E Diagnostic Tests Market- Geographical Insights

This market caters to a geographically scattered customer base, spanning North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Participating nations within these regions create sub-segments within the market. The hepatitis E diagnostic tests market in North America accounted for a significant share in 2023. The region's well-established healthcare infrastructure, comprising hospitals, diagnostic laboratories, and research centers, supports market growth by providing a conducive environment for the adoption of diagnostic tests. Additionally, government initiatives and funding for research and development in infectious disease diagnostics contribute to market growth by facilitating the development and adoption of new diagnostic solutions. For instance, in April 2024, Dr. Susan Hafenstein of The Hormel Institute at the University of Minnesota received an $85,000 NIH-funded grant from Nationwide Children's Hospital to support her cryoEM research into HEV, with the goal of creating new treatments and prevention strategies for hepatitis E.

Hepatitis E Diagnostic Tests Market- Competitive Landscape:

Companies in the hepatitis E diagnostic tests market employ various strategies to enhance competitiveness and expand their market reach. Emphasizing research and development is crucial, with efforts focused on improving test sensitivity and specificity, as well as creating rapid and point-of-care testing solutions. Strategic collaborations with healthcare institutions and laboratories help facilitate clinical validation and promote the widespread adoption of new tests. Marketing strategies highlight the importance of early detection in preventing complications, specifically targeting healthcare providers and public health agencies. Additionally, companies frequently engage in educational initiatives to raise awareness about the risks of hepatitis E and the availability of testing, ensuring that diagnostics become an integral part of liver health management.

Recent Developments:

In November 2023, Roche introduced two automated immunoassays, the Elecsys Anti-HEV IgG and the Elecsys Anti-HEV IgM, designed to detect hepatitis E virus infections. These tests are available in countries that recognize the CE mark, including members of the European Union.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altona Diagnostics
Dia.Pro Diagnostic Bioprobes srl
ELITechGroup
F. Hoffmann-La Roche Ltd
Fortress Diagnostics
Mikrogen GmbH
MP Biomedicals LLP
PerkinElmer, Inc
Primerdesign Ltd
Wantai BioPharm
Others

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

ELISA HEV IgM Test
ELISA HEV IgG Test
Rapid Diagnostics Test
Polymerase Chain Reaction (PCR)

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospital
Diagnostics Laboratories
Blood Banks
Other End User

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4064

1. Hepatitis E Diagnostic Tests Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hepatitis E Diagnostic Tests Market Snippet by Product Type
- 2.1.2. Hepatitis E Diagnostic Tests Market Snippet by End Use
- 2.1.3. Hepatitis E Diagnostic Tests Market Snippet by Country
- 2.1.4. Hepatitis E Diagnostic Tests Market Snippet by Region
2.2. Competitive Insights

3. Hepatitis E Diagnostic Tests Key Market Trends

3.1. Hepatitis E Diagnostic Tests Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hepatitis E Diagnostic Tests Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hepatitis E Diagnostic Tests Market Opportunities
3.4. Hepatitis E Diagnostic Tests Market Future Trends

4. Hepatitis E Diagnostic Tests Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hepatitis E Diagnostic Tests Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hepatitis E Diagnostic Tests Market Landscape

6.1. Hepatitis E Diagnostic Tests Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hepatitis E Diagnostic Tests Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. ELISA HEV IgM Test
- 7.1.3. ELISA HEV IgG Test
- 7.1.4. Rapid Diagnostics Test
- 7.1.5. Polymerase Chain Reaction (PCR)

8. Hepatitis E Diagnostic Tests Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 8.1.2. Hospital
- 8.1.3. Diagnostics Laboratories
- 8.1.4. Blood Banks
- 8.1.5. Other End User

9. Hepatitis E Diagnostic Tests Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Hepatitis E Diagnostic Tests Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Hepatitis E Diagnostic Tests Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Hepatitis E Diagnostic Tests Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Hepatitis E Diagnostic Tests Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Hepatitis E Diagnostic Tests Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hepatitis E Diagnostic Tests Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Altona Diagnostics
- 10.2.2. Dia.Pro Diagnostic Bioprobes srl
- 10.2.3. ELITechGroup
- 10.2.4. F. Hoffmann-La Roche Ltd
- 10.2.5. Fortress Diagnostics
- 10.2.6. Mikrogen GmbH
- 10.2.7. MP Biomedicals LLP
- 10.2.8. PerkinElmer, Inc
- 10.2.9. Primerdesign Ltd
- 10.2.10. Wantai BioPharm
- 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us